P557: LIFETIME CLINICAL OUTCOMES OF CPX-351 VERSUS 7 + 3 MODELED FROM THE 5-YEAR RESULTS OF A RANDOMIZED PHASE 3 TRIAL FOR OLDER ADULTS WITH NEWLY DIAGNOSED HIGH-RISK OR SECONDARY ACUTE MYELOID LEUKAEMIA
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Wiley
2023-08-01
|
| Collection: | HemaSphere |
| Accès en ligne: | http://journals.lww.com/10.1097/01.HS9.0000969136.52097.4e |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|